1371 / 1851
PCR
•
The Radiation Therapy Oncology Group
(RTOG) 0247 (A Randomized, Phase 2 Study of
Neoadjuvant Radiation Therapy Plus
Concurrent Capecitabine and Irinotecan or
Capecitabine and Oxaliplatin for Patients With
Locally Advanced Rectal Cancer)